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Salivary gland tumors account for 2–6.5% of all head-and-neck tumors [1], and among salivary gland neoplasm, basal cell adenoma (BCA) constitutes only 1–3%. BCA 
was first introduced by Kliensasser and Kleir in 1697, but it was 
recognized as a distinct disease entity in 1991 by the WHO [1]. 
It is characterized by uniform appearing basaloid cells arranged 
in a solid, tubular, trabecular, and membranous pattern. The 
characteristic feature of adenoma is a lack of myxoid and chondroid 
mesenchymal component. The absence of myoepithelial cells 
was also considered to be a characteristic feature of this tumor; 
however, the current reports suggest the role of myoepithelial 
cells in its histogenesis [2]. Here, we report a case of a 50-year-
old male patient with BCA of the parotid gland.
CASE REPORT
A 50-year-old patient reported in our hospital with a chief 
complaint of a painless swelling on the left pre-auricular region, 
which is gradually increasing in size for the past 1 year. The 
patient was a beedi smoker for the past 20 years. There was no 
history of fever and weight loss. The patient has not taken any 
prior treatment for the same.
On general physical examination, lymphadenopathy was 
present, and a well-circumscribed nodule, firm in the consistency 
of size 3 cm×3 cm was identified in the left preauricular area. 
The overlying skin was normal in color and was freely movable. 
Intraoral examination showed an absence of swelling. Other 
routine laboratory tests including hemoglobin, hematocrit, red 
blood cell counts, lactate dehydrogenase, bilirubin, and liver 
and kidney function tests showed no significant abnormality and 
were in normal range. On correlating the history and clinical 
examination, a provisional diagnosis of pleomorphic adenoma 
was given.
To know the extension and exact location of the tumor, 
computed tomography was planned, which showed enhancing 
nodular mass of size 5.4 cm×3.9 cm×3.2 cm in superficial lobe of 
the left parotid. No calcification and cystic lesion were noted. Fine-
needle aspiration cytology was performed and was suggestive 
of low-grade epithelial neoplasm, suspected as pleomorphic 
adenoma. However, the probabilities of malignancy could not 
be ruled out. Radical left parotidectomy with supraomohyoid 
neck dissection was done. On gross examination, the cut surface 
showed a capsulated well-circumscribed gray-white area of size 4 
cm×2.5 cm×2.5 cm, surrounded by normal salivary gland tissue.
Histopathological examination revealed a well-encapsulated 
lesion characterized by a biphasic population of cells arranged in 
sheets, which were separated by a thin eosinophilic membrane. 
The peripheral cells were small with hyperchromatic nuclei and 
show palisading arrangement, while the inner parts of the sheets 
were formed by large hypochromatic cells. Numerous ducts like 
structures were also seen, which were filled with eosinophilic 
material within the sheets (Fig. 1). Evidence of cartilage and 
myxoid stroma were not identified. Capsular invasion, perineural 
invasion, nuclear atypia, necrosis, and mitotic figures were 
not seen. Lymph nodes (level I to III) were negative for tumor 
involvement. The overall microscopic features were suggestive 
of BCA.
Further immunohistochemical (IHC) examination was 
planned to confirm the diagnosis. Low molecular weight 
cytokeratin (LMWCK), carcinoembryonic antigen (CEA), P63, 
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calponin, S100, and Ki67 were applied. Cells surrounding the 
ductal structures showed positivity for LMWCK and CEA. Rest 
of the tumor cells showed immunopositivity for P63; however, 
calponin and S100 were found to be negative. Ki67 index was 
<3%. The overall IHC profile confirmed our diagnosis of BCA 
(Fig. 2). All the soft tissue margins of resected specimen were 
evaluated and were found to be negative for tumor involvement. 
The patient was kept under regular follow-up for the past 2 years 
with no evidence of recurrence.
DISCUSSION
BCA is a rare, benign epithelial neoplasm of the salivary gland. 
It frequently occurs over 50 years of age, 3–8 cm in size as a 
unilateral well-circumscribed painless mass [3]. Histologically, 
four patterns have been described: Solid, trabecular, tubular, and 
membranous. They are characterized by the presence of uniform 
and regular basaloid cells with two different morphologies. One 
group of cells present at the periphery of tumor nests/islands is 
smaller cells with little cytoplasm and intensive basaloid-rounded 
nuclei. The other group of cells is placed centrally, which are 
larger cells with abundant cytoplasm and pale nuclei. A basement 
membrane-like eosinophilic structure surrounds the tumor nests 
separating them from surrounding stroma [4].
The microscopic findings of BCA are not very characteristic. 
Pleomorphic adenoma, basal cell adenocarcinoma, and adenoid 
cystic carcinoma are considered as differential diagnosis of 
BCA [4]. In basal cell adenocarcinoma, capsular invasion, 
necrosis, abnormal mitotic figures, increased mitotic activity, and 
perineural and vascular invasion can be seen [4]. The Ki 67 is 
also found to be more than 5% [5]. Adenoid cystic carcinoma 
is an invasive tumor, lacks capsulation, and shows perineural 
invasion. It lacks vascularity in the microcystic areas [6]. Since 
it is a malignant tumor, the expression of proliferating marker Ki 
67 ranges from 13.6% to 34.7%, while in BCA, it is <5% [3]. 
Pleomorphic adenoma shows variable histomorphology with the 
blending of cell cytoplasm to the adjacent stroma. It also shows 
myxoid/chondroid stroma which is not observed in BCA [3].
IHC analysis can help to rule out the differential diagnosis. 
BCA expresses variable IHC expression from tumor to tumor. 
However, overall, it supports the multidirectional differentiation 
into ductal, basal, and myoepithelial cells. It shows positivity for 
LMWCK, CEA, and EMA mainly confined to the cells surrounding 
ductal structures. Peripheral tumor cells located adjacent to 
connective tissue stroma show immunoreactivity for P63, S100, 
SMA, calponin, myosin, and vimentin, suggesting its association 
with myoepithelial cells [7]. P63 shows immunopositivity for 
both myoepithelial cells and basal cells; however, basal cells are 
immunonegative for S100 and calponin [8].
In our case, ductal cells (luminal cells) showed positivity for 
LMWCK and CEA. While the other component cells of tumor 
were positive for P63 and negative for S100 and Calponin, 
suggesting that the tumor was composed largely of basal cells. 
Ki67 was <3% and favors its benign nature. Overall, microscopic 
and IHC findings confirm the diagnosis of BCA. Primary 
treatment of BCA is surgical excision by means of a superficial/
Figure 1: (a) Tumor cells arranged in sheets and nests (×40). 
(b) Encapsulated tumor separated by fibrous capsule from 
surrounding normal tissue. (c) Tumor sheets are separated by 
eosinophilic membrane. Peripheral hyperchromatic cells with inner 
hypochromatic cells
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Figure 2: Immunohistochemical staining - (a) positivity for low molecular weight cytokeratin; (b) positivity for carcinoembryonic antigen; 
(c) positivity for P63;(d) No immunoreactivity for S100; (e) No immunoreactivity for calponin; (f) immunoreactivity for Ki 67
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total parotidectomy, and postoperatively, there is no role of 
chemotherapy/radiotherapy if excision performed adequately. In 
the membranous type of BCA, total parotidectomy is proposed 
due to an increased tendency of multicentricity and increased 
recurrence (25–37%) and malignant transformation rate (28%). 
Despite its benign behavior a long term follow-up is advisable to 
detect recurrence [9].
CONCLUSION
As BCA is now considered as a separate entity, we can expect 
an increase in its diagnosis. A comprehensive analysis of BCA 
is required with IHC analysis to differentiate it from the similar 
lesion. IHC patterning suggests the involvement of luminal and 
abluminal cells in its histogenesis. The role of myoepithelial cells 
in BCA is still a controversial issue and should be further studied. 
In any suspected neoplastic salivary gland tumor, differential 
diagnosis of its malignant counterpart should be ruled out.
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